Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial).

by John Hilton, Carol Stober, Sasha Mazzarello, Lisa Vandermeer, Dean Fergusson, Brian Hutton, Mark Clemons
Published 2018-01-01

Does the Time of Day at Which Endocrine Therapy Is Taken Affect Breast Cancer Patient Outcomes?

by Ana-Alicia Beltran-Bless, Lisa Vandermeer, Mohammed F. K. Ibrahim, Brian Hutton, Risa Shorr, Marie-France Savard, Mark Clemons
Published 2021-07-01

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

by Mashari AlZahrani, Mark Clemons, Lisa Vandermeer, Marta Sienkiewicz, Arif Ali Awan, Brian Hutton, Gregory R. Pond, Terry L. Ng
Published 2021-02-01

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

by Ricardo Fernandes, Sasha Mazzarello, Carol Stober, Mohamed F.K. Ibrahim, Shaan Dudani, Kirstin Perdrizet, Habeeb Majeed, Lisa Vandermeer, Risa Shorr, Brian Hutton, Dean Fergusson, Bishal Gyawali, Mark Clemons
Published 2017-04-01

Cost-Effectiveness Analysis of 12-Versus 4-Weekly Administration of Bone-Targeted Agents in Patients with Bone Metastases from Breast and Castration-Resistant Prostate Cancer

by Megan M. Tu, Mark Clemons, Carol Stober, Ahwon Jeong, Lisa Vandermeer, Mihaela Mates, Phillip Blanchette, Anil Abraham Joy, Olexiy Aseyev, Gregory Pond, Dean Fergusson, Terry L. Ng, Kednapa Thavorn
Published 2021-05-01

Adjuvant bisphosphonate use in patients with early stage breast cancer: Patient perspectives on treatment acceptability and potential de-escalation

by Sharon McGee, Mashari AlZahrani, Carol Stober, Terry L. Ng, Katherine Cole, Gail Larocque, Arif Awan, Sandeep Sehdev, John Hilton, Lisa Vandermeer, Brian Hutton, Gregory Pond, Deanna Saunders, Mark Clemons
Published 2021-04-01

Feasibility outcomes of a randomised, multicentre, pilot trial comparing standard 6-monthly dosing of adjuvant zoledronate with a single one-time dose in patients with early stage...

by Arif Awan, Terry Ng, Henry Conter, William Raskin, Carol Stober, Demetrios Simos, Greg Pond, Sukhbinder Dhesy-Thind, Mihaela Mates, Vikaash Kumar, Dean Fergusson, Brian Hutton, Deanna Saunders, Lisa Vandermeer, Mark Clemons
Published 2021-02-01

Optimising weight-loss interventions in cancer patients-A systematic review and network meta-analysis.

by Nathalie LeVasseur, Wei Cheng, Sasha Mazzarello, Mark Clemons, Lisa Vandermeer, Lee Jones, Anil Abraham Joy, Pauline Barbeau, Dianna Wolfe, Nadera Ahmadzai, Mona Hersi, Carol Stober, Risa Shorr, John Hilton, Brian Hutton
Published 2021-01-01

A Randomized Controlled Trial Comparing Alloderm-RTU with DermACELL in Immediate Subpectoral Implant-Based Breast Reconstruction

by Angel Arnaout, Jing Zhang, Simon Frank, Moein Momtazi, Erin Cordeiro, Amanda Roberts, Ammara Ghumman, Dean Fergusson, Carol Stober, Gregory Pond, Ahwon Jeong, Lisa Vandermeer, Brian Hutton, Mark Clemons, on behalf of the REaCT Investigators
Published 2021-12-01

Two-year results of a randomised trial comparing 4- versus 12-weekly bone-targeted agent use in patients with bone metastases from breast or castration-resistant prostate cancer

by Mark Clemons, Michelle Liu, Carol Stober, Gregory Pond, Mashari Jemaan Alzahrani, Michael Ong, Scott Ernst, Christopher Booth, Mihaela Mates, Anil Abraham Joy, Olexiy Aseyev, Phillip Blanchette, Lisa Vandermeer, Megan Tu, Kednapa Thavorn, Dean Fergusson
Published 2021-10-01

A multi-centre study comparing granulocyte-colony stimulating factors to antibiotics for primary prophylaxis of docetaxel-cyclophosphamide induced febrile neutropenia

by Mark Clemons, Dean Fergusson, Anil A. Joy, Kednapa Thavorn, Judith Meza-Junco, Julie Price Hiller, John Mackey, Terry Ng, Xiaofu Zhu, Mohammed F.K. Ibrahim, Marta Sienkiewicz, Deanna Saunders, Lisa Vandermeer, Gregory Pond, Bassam Basulaiman, Arif Awan, Lacey Pitre, Nancy A. Nixon, Brian Hutton, John F. Hilton
Published 2021-08-01